Report Detail

Request for Sample of this report

Service & Software Global Biomarker Clinical Phase Outsourcing Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4764849
    • |
  • 29 October, 2026
    • |
  • Global
    • |
  • 107 Pages
    • |
  • GIR
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global Biomarker Clinical Phase Outsourcing Services market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Biomarker Clinical Phase Outsourcing Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biomarker Clinical Phase Outsourcing Services market size and forecasts, in consumption value ($ Million), 2021-2032
Global Biomarker Clinical Phase Outsourcing Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Biomarker Clinical Phase Outsourcing Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Biomarker Clinical Phase Outsourcing Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biomarker Clinical Phase Outsourcing Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biomarker Clinical Phase Outsourcing Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ICON plc, Fujirebio lnc, Charles River Laboratories International,Inc., Laboratory Corporation of America Holdings, Parexel lnternational Corporation, Proteome Sciences plc, Eurofins Scientific, Wuxi AppTec Co., Ltd., NorthEast BioAnalytical Laboratories LLC., Celerion, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Biomarker Clinical Phase Outsourcing Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Predictive Biomarker
Prognostic Biomarker
Safety Biomarker
Surrogate Endpoints
Market segment by Application
Pharmaceutical Companies
Biotechnology Companies
Others
Market segment by players, this report covers
ICON plc
Fujirebio lnc
Charles River Laboratories International,Inc.
Laboratory Corporation of America Holdings
Parexel lnternational Corporation
Proteome Sciences plc
Eurofins Scientific
Wuxi AppTec Co., Ltd.
NorthEast BioAnalytical Laboratories LLC.
Celerion, Inc.
GenScript ProBio Co.,Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biomarker Clinical Phase Outsourcing Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biomarker Clinical Phase Outsourcing Services, with revenue, gross margin, and global market share of Biomarker Clinical Phase Outsourcing Services from 2021 to 2026.
Chapter 3, the Biomarker Clinical Phase Outsourcing Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Biomarker Clinical Phase Outsourcing Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biomarker Clinical Phase Outsourcing Services.
Chapter 13, to describe Biomarker Clinical Phase Outsourcing Services research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Biomarker Clinical Phase Outsourcing Services by Type
    • 1.3.1 Overview: Global Biomarker Clinical Phase Outsourcing Services Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Biomarker Clinical Phase Outsourcing Services Consumption Value Market Share by Type in 2025
    • 1.3.3 Predictive Biomarker
    • 1.3.4 Prognostic Biomarker
    • 1.3.5 Safety Biomarker
    • 1.3.6 Surrogate Endpoints
  • 1.4 Global Biomarker Clinical Phase Outsourcing Services Market by Application
    • 1.4.1 Overview: Global Biomarker Clinical Phase Outsourcing Services Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Pharmaceutical Companies
    • 1.4.3 Biotechnology Companies
    • 1.4.4 Others
  • 1.5 Global Biomarker Clinical Phase Outsourcing Services Market Size & Forecast
  • 1.6 Global Biomarker Clinical Phase Outsourcing Services Market Size and Forecast by Region
    • 1.6.1 Global Biomarker Clinical Phase Outsourcing Services Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Biomarker Clinical Phase Outsourcing Services Market Size by Region, (2021-2032)
    • 1.6.3 North America Biomarker Clinical Phase Outsourcing Services Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Biomarker Clinical Phase Outsourcing Services Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market Size and Prospect (2021-2032)
    • 1.6.6 South America Biomarker Clinical Phase Outsourcing Services Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 ICON plc
    • 2.1.1 ICON plc Details
    • 2.1.2 ICON plc Major Business
    • 2.1.3 ICON plc Biomarker Clinical Phase Outsourcing Services Product and Solutions
    • 2.1.4 ICON plc Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 ICON plc Recent Developments and Future Plans
  • 2.2 Fujirebio lnc
    • 2.2.1 Fujirebio lnc Details
    • 2.2.2 Fujirebio lnc Major Business
    • 2.2.3 Fujirebio lnc Biomarker Clinical Phase Outsourcing Services Product and Solutions
    • 2.2.4 Fujirebio lnc Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Fujirebio lnc Recent Developments and Future Plans
  • 2.3 Charles River Laboratories International,Inc.
    • 2.3.1 Charles River Laboratories International,Inc. Details
    • 2.3.2 Charles River Laboratories International,Inc. Major Business
    • 2.3.3 Charles River Laboratories International,Inc. Biomarker Clinical Phase Outsourcing Services Product and Solutions
    • 2.3.4 Charles River Laboratories International,Inc. Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Charles River Laboratories International,Inc. Recent Developments and Future Plans
  • 2.4 Laboratory Corporation of America Holdings
    • 2.4.1 Laboratory Corporation of America Holdings Details
    • 2.4.2 Laboratory Corporation of America Holdings Major Business
    • 2.4.3 Laboratory Corporation of America Holdings Biomarker Clinical Phase Outsourcing Services Product and Solutions
    • 2.4.4 Laboratory Corporation of America Holdings Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
  • 2.5 Parexel lnternational Corporation
    • 2.5.1 Parexel lnternational Corporation Details
    • 2.5.2 Parexel lnternational Corporation Major Business
    • 2.5.3 Parexel lnternational Corporation Biomarker Clinical Phase Outsourcing Services Product and Solutions
    • 2.5.4 Parexel lnternational Corporation Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Parexel lnternational Corporation Recent Developments and Future Plans
  • 2.6 Proteome Sciences plc
    • 2.6.1 Proteome Sciences plc Details
    • 2.6.2 Proteome Sciences plc Major Business
    • 2.6.3 Proteome Sciences plc Biomarker Clinical Phase Outsourcing Services Product and Solutions
    • 2.6.4 Proteome Sciences plc Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Proteome Sciences plc Recent Developments and Future Plans
  • 2.7 Eurofins Scientific
    • 2.7.1 Eurofins Scientific Details
    • 2.7.2 Eurofins Scientific Major Business
    • 2.7.3 Eurofins Scientific Biomarker Clinical Phase Outsourcing Services Product and Solutions
    • 2.7.4 Eurofins Scientific Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Eurofins Scientific Recent Developments and Future Plans
  • 2.8 Wuxi AppTec Co., Ltd.
    • 2.8.1 Wuxi AppTec Co., Ltd. Details
    • 2.8.2 Wuxi AppTec Co., Ltd. Major Business
    • 2.8.3 Wuxi AppTec Co., Ltd. Biomarker Clinical Phase Outsourcing Services Product and Solutions
    • 2.8.4 Wuxi AppTec Co., Ltd. Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Wuxi AppTec Co., Ltd. Recent Developments and Future Plans
  • 2.9 NorthEast BioAnalytical Laboratories LLC.
    • 2.9.1 NorthEast BioAnalytical Laboratories LLC. Details
    • 2.9.2 NorthEast BioAnalytical Laboratories LLC. Major Business
    • 2.9.3 NorthEast BioAnalytical Laboratories LLC. Biomarker Clinical Phase Outsourcing Services Product and Solutions
    • 2.9.4 NorthEast BioAnalytical Laboratories LLC. Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 NorthEast BioAnalytical Laboratories LLC. Recent Developments and Future Plans
  • 2.10 Celerion, Inc.
    • 2.10.1 Celerion, Inc. Details
    • 2.10.2 Celerion, Inc. Major Business
    • 2.10.3 Celerion, Inc. Biomarker Clinical Phase Outsourcing Services Product and Solutions
    • 2.10.4 Celerion, Inc. Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Celerion, Inc. Recent Developments and Future Plans
  • 2.11 GenScript ProBio Co.,Ltd.
    • 2.11.1 GenScript ProBio Co.,Ltd. Details
    • 2.11.2 GenScript ProBio Co.,Ltd. Major Business
    • 2.11.3 GenScript ProBio Co.,Ltd. Biomarker Clinical Phase Outsourcing Services Product and Solutions
    • 2.11.4 GenScript ProBio Co.,Ltd. Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 GenScript ProBio Co.,Ltd. Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Biomarker Clinical Phase Outsourcing Services Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Biomarker Clinical Phase Outsourcing Services by Company Revenue
    • 3.2.2 Top 3 Biomarker Clinical Phase Outsourcing Services Players Market Share in 2025
    • 3.2.3 Top 6 Biomarker Clinical Phase Outsourcing Services Players Market Share in 2025
  • 3.3 Biomarker Clinical Phase Outsourcing Services Market: Overall Company Footprint Analysis
    • 3.3.1 Biomarker Clinical Phase Outsourcing Services Market: Region Footprint
    • 3.3.2 Biomarker Clinical Phase Outsourcing Services Market: Company Product Type Footprint
    • 3.3.3 Biomarker Clinical Phase Outsourcing Services Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Biomarker Clinical Phase Outsourcing Services Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Biomarker Clinical Phase Outsourcing Services Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Biomarker Clinical Phase Outsourcing Services Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Biomarker Clinical Phase Outsourcing Services Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Biomarker Clinical Phase Outsourcing Services Consumption Value by Type (2021-2032)
  • 6.2 North America Biomarker Clinical Phase Outsourcing Services Market Size by Application (2021-2032)
  • 6.3 North America Biomarker Clinical Phase Outsourcing Services Market Size by Country
    • 6.3.1 North America Biomarker Clinical Phase Outsourcing Services Consumption Value by Country (2021-2032)
    • 6.3.2 United States Biomarker Clinical Phase Outsourcing Services Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Biomarker Clinical Phase Outsourcing Services Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Biomarker Clinical Phase Outsourcing Services Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Biomarker Clinical Phase Outsourcing Services Consumption Value by Type (2021-2032)
  • 7.2 Europe Biomarker Clinical Phase Outsourcing Services Consumption Value by Application (2021-2032)
  • 7.3 Europe Biomarker Clinical Phase Outsourcing Services Market Size by Country
    • 7.3.1 Europe Biomarker Clinical Phase Outsourcing Services Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Biomarker Clinical Phase Outsourcing Services Market Size and Forecast (2021-2032)
    • 7.3.3 France Biomarker Clinical Phase Outsourcing Services Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Biomarker Clinical Phase Outsourcing Services Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Biomarker Clinical Phase Outsourcing Services Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Biomarker Clinical Phase Outsourcing Services Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Biomarker Clinical Phase Outsourcing Services Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Biomarker Clinical Phase Outsourcing Services Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market Size by Region
    • 8.3.1 Asia-Pacific Biomarker Clinical Phase Outsourcing Services Consumption Value by Region (2021-2032)
    • 8.3.2 China Biomarker Clinical Phase Outsourcing Services Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Biomarker Clinical Phase Outsourcing Services Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Biomarker Clinical Phase Outsourcing Services Market Size and Forecast (2021-2032)
    • 8.3.5 India Biomarker Clinical Phase Outsourcing Services Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Biomarker Clinical Phase Outsourcing Services Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Biomarker Clinical Phase Outsourcing Services Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Biomarker Clinical Phase Outsourcing Services Consumption Value by Type (2021-2032)
  • 9.2 South America Biomarker Clinical Phase Outsourcing Services Consumption Value by Application (2021-2032)
  • 9.3 South America Biomarker Clinical Phase Outsourcing Services Market Size by Country
    • 9.3.1 South America Biomarker Clinical Phase Outsourcing Services Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Biomarker Clinical Phase Outsourcing Services Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Biomarker Clinical Phase Outsourcing Services Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Biomarker Clinical Phase Outsourcing Services Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Biomarker Clinical Phase Outsourcing Services Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size by Country
    • 10.3.1 Middle East & Africa Biomarker Clinical Phase Outsourcing Services Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Biomarker Clinical Phase Outsourcing Services Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Biomarker Clinical Phase Outsourcing Services Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Biomarker Clinical Phase Outsourcing Services Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Biomarker Clinical Phase Outsourcing Services Market Drivers
  • 11.2 Biomarker Clinical Phase Outsourcing Services Market Restraints
  • 11.3 Biomarker Clinical Phase Outsourcing Services Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Biomarker Clinical Phase Outsourcing Services Industry Chain
  • 12.2 Biomarker Clinical Phase Outsourcing Services Upstream Analysis
  • 12.3 Biomarker Clinical Phase Outsourcing Services Midstream Analysis
  • 12.4 Biomarker Clinical Phase Outsourcing Services Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Biomarker Clinical Phase Outsourcing Services. Industry analysis & Market Report on Biomarker Clinical Phase Outsourcing Services is a syndicated market report, published as Global Biomarker Clinical Phase Outsourcing Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Biomarker Clinical Phase Outsourcing Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo